Nanomedicine-Mediated Autophagy Modulation in Placental Impairment Versus Cancers: A Narrative Review
Pharmaceutics · 30.06.2026 · 18 (7) · 809
DOI: 10.3390/pharmaceutics18070809 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 30.06.2026. Verfasst von Melinda Ildiko Mitranovici und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Emergency County Hospital Hunedoara, 331057 Hunedoara, Romania. Die Arbeit nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The biggest challenge faced by classical anticancer therapy is drug resistance, which causes cancer recurrence and metastasis. Two underlying mechanisms could be responsible, including the stemness of pro-survival autophagy-associated cancer stem cells (CSCs). Background/Objectives: The relationship between CSCs and autophagy in gynecological cancer is still unknown. However, it has been shown that CSCs’ in vitro self-renewal ability is decreased when autophagy is inhibited. Helping to maintain normal tissue homeostasis, autophagy is a catabolic process involved in degrading long-lived proteins and cytoplasmic organelles. Autophagy acts as a key player in the human body’s self-regenerating tissues. It also has a reproductive function, contributing to decidualization for a successful pregnancy. The aim of our review is to identify similarities and differences between these processes, using these findings to discover new therapeutic strategies through nanotechnology.
Method
We conducted a narrative review, identifying heterogeneity in the data in the literature, and found 153 relevant articles. Discussions: While autophagy has been proven to be capable of acting as a tumor suppressor, it also promotes tumor progression. Moreover, it has been linked to cancer stem cell regulation, therapy resistance, cancer invasion, and metastasis. Several molecular mechanisms have been linked to autophagy. Remarkably, some cellular processes required for proper placentation, including autophagy, are common between placental development and tumor growth. Just as trophoblast cells invade and migrate, so do cancer cells. While in the trophoblast, this phenomenon is programmed and controlled; in cancer, this regulation is lost. As shown, we thus observed commonalities and discrepancies in the phenotypes and underlying molecular mechanisms of autophagy regulation in preeclampsia versus cancer contexts. Translational applicability of nanomedicine research strategies and design paradigms between preeclampsia intervention and cancer therapy has been sought.
Conclusions
Autophagy-based nanotechnology seems to be feasible in both placental ischemia in preeclampsia and cancers. This review draws parallels between targeted treatments in malignancies and placenta-derived PE. Comparing these diseases provides a novel molecular rationale and the possibility of identifying treatment through autophagy modulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Emergency County Hospital Hunedoara, 331057 Hunedoara, Romania.
- Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
- Department of Cardiology, "Victor Babes" University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania.
- Department of Anatomy, University of Medicine, Pharmacy, Sciences and Technology "George Emil Palade", 540142 Targu Mures, Romania.
- Department of Epidemiology, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania.
- Department of Pathophysiology, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 38 Gheorghe Marinescu Street, 540142 Targu Mures, Romania.
ORCID-Profile: Melinda Ildiko Mitranovici, Viviana Ivan, Adrian Apostol, Septimiu Voidazan, Raluca Niculescu, Ioana Cristina Rotar, Andreea Taisia Tiron, Laura Georgiana Caravia
Zitieren
APA
Mitranovici, M. I., Ivan, V., Apostol, A., Moraru, L., Voidazan, S., Niculescu, R., Rotar, I. C., Bobirca, F., Tiron, A. T., & Caravia, L. G. (2026). Nanomedicine-Mediated Autophagy Modulation in Placental Impairment Versus Cancers: A Narrative Review. Pharmaceutics, 18(7), 809. https://doi.org/10.3390/pharmaceutics18070809
Vancouver
Mitranovici MI, Ivan V, Apostol A, Moraru L, Voidazan S, Niculescu R, et al. Nanomedicine-Mediated Autophagy Modulation in Placental Impairment Versus Cancers: A Narrative Review. Pharmaceutics. 2026;18(7):809. doi:10.3390/pharmaceutics18070809
BibTeX
@article{Mitranovici2026,
author = {Mitranovici, Melinda Ildiko and Ivan, Viviana and Apostol, Adrian and Moraru, Liviu and Voidazan, Septimiu and Niculescu, Raluca and Rotar, Ioana Cristina and Bobirca, Florin and Tiron, Andreea Taisia and Caravia, Laura Georgiana},
title = {Nanomedicine-Mediated Autophagy Modulation in Placental Impairment Versus Cancers: A Narrative Review},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {7},
pages = {809},
doi = {10.3390/pharmaceutics18070809}
}
EUVIMED